4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-6-carbonitrile

Catalog No.: 
ACWLMP763
CAS No.: 
1231926-34-3
Molecular Formula: 
C16H17BN2O2
Molecular Weight: 
280.14
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-6-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-6-carbonitrile
IUPAC Name4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-6-carbonitrile
Molecular FormulaC16H17BN2O2
Molecular Weight280.14
SMILESCC1(C)C(C)(C)OB(C2=C3C=C(C#N)C=CC3=NC=C2)O1
InChI KeyLKASAUFRMGYTNZ-UHFFFAOYSA-N
Synonym4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline-6-carbonitrile;6-Quinolinecarbonitrile, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1231926-34-3

Synthetic Route by SureRoute

1. ACWLMP763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. ACLJOV702 route compound structure diagram
    ACLJOV702219763-83-4In Stock
  4. Then
  5. ACWLMP763 route product structure diagram
    ACWLMP7631231926-34-3
Inquiry

2. ACWLMP763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWLMP763 route product structure diagram
    ACWLMP7631231926-34-3
Inquiry

3. ACWLMP763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACWLMP763 route product structure diagram
    ACWLMP7631231926-34-3
Inquiry

Comments (0)